Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

80154 Press Releases
DateTitleCompany
03 Jul 15 aap: Supervisory Board extends contract of CFO Marek Hahn prematurely until end of 2017 aap Implantate AG,
Published by
GlobeNewswire
03 Jul 15 Progress in clinical trials for the FDA application for The NGAL Test™ and launch of new generic strip test Published by
GlobeNewswire
03 Jul 15 CellaVision has received a follow-up order in excess of SEK 30 million from the veterinary market. Published by
GlobeNewswire
03 Jul 15 CellaVision AB revises its financial target for operating margin from 15% to 20% over an economic cycle. Published by
GlobeNewswire
03 Jul 15 CellaVision has received a follow-up order in excess of SEK 30 million from the veterinary market. CellaVision AB,
Published by
GlobeNewswire
03 Jul 15 CellaVision AB revises its financial target for operating margin from 15% to 20% over an economic cycle. CellaVision AB,
Published by
GlobeNewswire
03 Jul 15 Japan’s Ministry of Health, Labour and Welfare Approves Gilead’s Harvoni®, the First Once-Daily Single Tablet Regimen for the Treatment of Genotype 1 Chronic Hepatitis C Gilead Sciences, Inc.,
Published by
Business Wire
03 Jul 15 Bidding for Health charity auction goes live online! Immunodeficiency Canada,
Published by
PR Newswire
03 Jul 15 DBV Technologies announces the filing of a registration statement on Form F-1 in view of an offering of new shares in the form of American Depositary Shares, and the filing of its Reference Document Published by
GlobeNewswire
03 Jul 15 NeuroDerm Ltd. Files Registration Statement for Proposed Follow-On Offering Published by
GlobeNewswire
03 Jul 15 Navidea Biopharmaceuticals and Macrophage Therapeutics to Host Post-International KSHV Conference Summary Webcast Navidea Biopharmaceuticals, Inc.,
Published by
Business Wire
02 Jul 15 Auris Medical Holding AG Provides Update on U.S. Intellectual Property Portfolio Published by
GlobeNewswire
02 Jul 15 Revance Therapeutics Announces Change in Role of Jacob Waugh, M.D. Published by
GlobeNewswire
02 Jul 15 Medifast's Guy Sheetz Named to The Daily Record's VIP List Medifast, Inc.,
Published by
PR Newswire
02 Jul 15 Healthcare Realty Trust Announces Sale Of Two Properties For $97.0 Million Healthcare Realty Trust Incorporated,
Published by
PR Newswire
02 Jul 15 Ignyta to Present at Cantor Fitzgerald Healthcare Conference Ignyta, Inc.,
Published by
Business Wire
02 Jul 15 ADDING MULTIMEDIA FDA Approves ORKAMBI™ (lumacaftor/ivacaftor) - the First Medicine to Treat the Underlying Cause of Cystic Fibrosis for People Ages 12 and Older with Two Copies of the F508del Mutation Vertex Pharmaceuticals Incorporated,
Published by
Business Wire
02 Jul 15 Intersect ENT to Present at Cantor Fitzgerald’s Inaugural Healthcare Conference Intersect ENT, Inc.,
Published by
Business Wire
02 Jul 15 Pfizer Announces FDA Acceptance for Review of New Drug Application for A Once-Daily Formulation of XELJANZ® (tofacitinib citrate) Modified Release Tablets Pfizer Inc.,
Published by
Business Wire
02 Jul 15 BioCorRx, Inc. and Sobriety and Addiction Solutions, LLC Announce Mutual Separation; Plan to Advocate for Wider Naltrexone Implant Use in the Treatment of Addiction Published by
GlobeNewswire
02 Jul 15 Farlie Turner's Consumer Group Completes Sale of Insight Beverages to Kerry Farlie Turner & Co.,
Published by
PR Newswire
02 Jul 15 FDA Approves ORKAMBI™ (lumacaftor/ivacaftor) - the First Medicine to Treat the Underlying Cause of Cystic Fibrosis for People Ages 12 and Older with Two Copies of the F508del Mutation Vertex Pharmaceuticals Incorporated,
Published by
Business Wire
02 Jul 15 Cystic Fibrosis Foundation Celebrates FDA Approval of Orkambi as an Important Advance for the Cystic Fibrosis Community Cystic Fibrosis Foundation,
Published by
Business Wire
02 Jul 15 Viventia Begins Recruitment of Clinical Centers as it Prepares to Initiate Phase 3 Clinical Trial of Vicinium(TM) for the Treatment of Non-Muscle-Invasive Bladder Cancer Published by
GlobeNewswire
02 Jul 15 Half year update on the DBV Technologies liquidity agreement Published by
GlobeNewswire
02 Jul 15 AB Science: the Data and Safety Monitoring Board recommends continuation of three phase 2 studies Published by
GlobeNewswire
02 Jul 15 Photo Release -- AXIM Biotechnologies, Inc. Supports Adopt-A-Soldier Platoon's Warfighter Independence Weekend Published by
GlobeNewswire
02 Jul 15 Dr. Pierre-Andre Wicker joins Pharmaleads' Board of Directors Published by
GlobeNewswire
02 Jul 15 Data Demonstrates Durability of Medtronic's VenaSeal Closure System, a Non-Tumescent, Non-Thermal and Non-Sclerosant Procedure for Chronic Venous Insufficiency Medtronic plc,
Published by
GlobeNewswire
02 Jul 15 Dr. Pierre-André Wicker joins Pharmaleads' Board of Directors Pharmaleads,
Published by
GlobeNewswire
Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.